Home / Drug shortages / Anagrelide Hydrochloride Capsule

Anagrelide Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Anagrelide Hydrochloride Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 11/19/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0172-5240-60
Dosage Form
Capsule
Presentation
Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)
Initial Posting
11/19/2025
Revised Date

FDA data resources